GGrantIndex
← Leaderboards

Children'S Mercy Hosp (Kansas City, Mo)

Kansas City, MO

Compare ↔
$143,136,412
Total funding
109
Grants

Funding over time

peak $14.9M · FY2005–25
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$121,368,162 · 102
CDC$23,165,885 · 5
AHRQ$876,814 · 2
FDA$49,957 · 1

By mechanism

U01$52,711,896 · 10
R01$52,096,409 · 32
K23$8,746,589 · 17
R21$6,223,053 · 17
U10$4,434,572 · 2
U54$3,096,983 · 3

Investigators at Children'S Mercy Hosp (Kansas City, Mo)

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Scott T Younger$2,179,1041 gr2Craig Smail$1,985,8802 gr3Tomi Pastinen$1,526,1863 gr4John Patrick Dahl$467,9251 gr5Genevieve Bernard$423,4341 gr6Jennifer Kasemeier$397,5001 gr7Henry Thomas Puls$346,4591 gr8Matthew McLaughlin$318,6721 gr

Emerging Leaders

6–10 yrs in

1Elin Grundberg$5,273,6064 gr2Todd Christopher Bradley$4,720,0553 gr3Andrea Gaedigk$1,942,2231 gr4Jennifer Lynn Goldman$1,798,2362 gr5Jeffrey D Colvin$1,243,2513 gr6Emily Farrow$421,1321 gr7Christopher Ryan Nitkin$230,3651 gr8Rachel Chevalier$150,0001 gr

All-Time

Most funded here, all years

1George K. Gittes$11,723,97310 gr2Venkatesh Sampath$7,069,3197 gr3Elin Grundberg$5,273,6064 gr4Todd Christopher Bradley$4,720,0553 gr5James Steven Leeder$2,815,9465 gr6Bridgette L. Jones$2,494,1691 gr7Scott T Younger$2,179,1041 gr8Andrew L Gilman$2,092,5071 gr

Largest grants

IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children$2,749,996
U01 · FY2023 · IP
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children$2,300,000
U01 · FY2023 · IP
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children$2,000,000
U01 · FY2025 · IP
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children$1,936,000
U01 · FY2022 · IP
Characterization of Sedentary Patterns and Cardiovascular Disease Risk Markers in Hispanics/Latinos$1,671,646
R01 · FY2019 · HL
Kansas City - New Vaccine Surveillance Network (KC-NVSN)$1,505,484
U01 · FY2020 · IP
Characterization of Sedentary Patterns and Cardiovascular Disease Risk Markers in Hispanics/Latinos$1,444,166
R01 · FY2020 · HL
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children$1,441,647
U01 · FY2021 · IP
Characterization of Sedentary Patterns and Cardiovascular Disease Risk Markers in Hispanics/Latinos$1,353,839
R01 · FY2021 · HL
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children$1,234,285
U01 · FY2024 · IP
Kansas City - New Vaccine Surveillance Network (KC-NVSN)$1,226,942
U01 · FY2018 · IP
Clinical and Social Implications of 2-day Genome Results in Acutely III Newborns$1,183,128
U19 · FY2013 · HD
Chronic Kidney Disease in Children (CKiD V)$1,166,170
U01 · FY2023 · DK
Clinical and Social Implications of 2-day Genome Results in Acutely III Newborns$1,141,278
U19 · FY2014 · HD
Chronic Kidney Disease in Children (CKiD V)$1,124,419
U01 · FY2024 · DK
Chronic Kidney Disease in Children (CKiD V)$1,034,674
U01 · FY2025 · DK
Chronic Kidney Disease in Children (CKiD III)$1,016,466
U01 · FY2014 · DK
Chronic Kidney Disease in Children (CKiD III)$1,007,756
U01 · FY2015 · DK
Chronic Kidney Disease in Children (CKiD IV)$1,004,499
U01 · FY2018 · DK
Chronic Kidney Disease in Children (CKiD)$1,004,040
U01 · FY2009 · DK